해외 소식

Corporate News

2016 · 2015 · 2014 · 2013 ·
  • For Geistlich, it was 20+30=1000 for a year. The results.

  • Geistlich Pharma has dedicated itself to regenerative medicine – for increased patient quality of life. This Swiss family business is remaining true to this aim with its 2016 annual charitable donation to Mercy Ships. Through hospital ships the aid organization with Swiss roots provides free medical aid to developing countries.

  • On 10 November 2016 Geistlich Pharma welcomed 20 girls and boys on the occasion of Switzerland’s National Future Day. The children aged between 10 and 13 were there to get an idea of the different kinds of work undertaken in this Swiss family business specializing in regenerative medicine.

  • Bone augmentation, recession coverage, sinus lift – topics that are sometimes difficult to understand for patients. To enable dentists to easily brief patients on their forthcoming treatment, Geistlich Pharma is providing a Patient Information Package specially prepared for patients and dentists.

  • Geistlich took part in the EAO Congress from September 29 to October 1, 2016 in Paris. With around 2,700 visitors, the annual congress of the European Association for Osseointegration was a very popular event. The visitor numbers were also high for Geistlich: The Satellite Symposium and Hands-on Workshops, with highly regarded expert speakers, attracted a lot of interest. A further highlight was the product launch of Geistlich Bio-Gide® Compressed.

  • At the EAO in Paris, Geistlich Pharma AG launched the new member of their family of membrane products. Geistlich Bio-Gide® Compressed is a native bilayer collagen membrane specially designed for dentists who prefer membranes with alternative handling properties compared to the No. 1 membrane in regenerative dentistry: Geistlich Bio-Gide®.1,2

  • “Cell-to-Cell Communication: Guided Bone Regeneration” is a masterful animation movie from Quintessence Publishing Group. Geistlich Biomaterials supported the production and now offers an exclusive short version.

  • On October 8, Geistlich Pharma AG celebrated the opening of their tenth subsidiary, in India. The business was officially launched in the presence of the Swiss ambassador, Dr Andreas Baum, and marks Geistlich’s advance into a potentially very interesting market for the global leader in regenerative dentistry (Geistlich Biomaterials).

  • Our experts discuss “Diagnostics and planning” – tailored to regenerative therapies.

  • A recently published study with 10 yrs of data shows that autologous bone blocks resorb only minimally if they are protected by a slowly resorbing bone substitute and a collagen membrane.1

PRESS CONTACT
Mirjam_Kessler_140x140.jpg
Dr. Mirjam Kessler
Director Corporate Communications
Flickr

For printable images, please send an e-mail to mediageistlich.ch

YouTube

Geistlich Pharma AG - Channel­